Bullpen.News From Edwin Dorsey
Get Daily Recap Feedback

Friday, November 6, 2026

Back to the front page

Post Q3 EVC Update

EVC's Q3 update cites $30 million for a single station, a broadcast-business sale and stronger positioning for 2027.

EVC $832M
Nat Stewart - Stock Picking Newsletter 23 clicks

From X

@StableBread

Fajasy on X

I compared the 8-K on Quantum’s $QMCO CFO firing to the one on its chief accounting officer’s exit in August. $QMCO terminated William White as CFO on October 9, 2026, effective immediately, eight months after appointing him on February 2, 2026. When I first wrote up $QMCO on May 6, White was its newly appointed CFO, after the seat had been empty since August 2025. The 8-K gives no reason, and I found no press release about the firing on $QMCO’s investor relations site. Instead, the 8-K says $QMCO expects to file its September-quarter 10-Q on time. The filing also says $QMCO expects to meet or exceed its guidance for the quarter, even though it was still “early in its financial closing process.” Chief accounting officer Hiral Patel took over as principal financial officer, so she now signs off on $QMCO’s financial statements with the CEO. Patel only joined $QMCO on September 1, after the company decided on August 11 to replace Laura Nash as chief accounting officer. The 8-K on Nash says there are “no disagreements” between her and the company, but the one on White doesn’t say either way. So within two months, $QMCO replaced both of its top finance officers. $QMCO’s June-quarter 10-Q still reports material weaknesses (the most serious kind of gap in a company’s financial reporting controls) in revenue recognition, inventory, and income taxes. It also says $QMCO “lacked sufficiently qualified staff or resources to perform control activities.” None of the weaknesses has led to a material misstatement, but $QMCO has restated its financial statements before, in May 2024 and again in August 2025. In my May 6 write-up, I listed restatements as a risk that could break the story, and wrote that a third “would be a serious credibility hit.” $QMCO expected to fix one of its three revenue weaknesses, the schedules that set when service revenue is recognized, by the end of the September quarter. Its June-quarter 10-Q was also officially filed on August 11, a day after its 40-day deadline, and its FY2026 10-K needed a notice of late filing in June. So with open material weaknesses, a history of restatements, and a 10-Q filed a day late in August, I’d rather see the September-quarter 10-Q, due November 9, before taking $QMCO at its word.
@ACapitalLP 1 click

A Capital on X

Interesting setup in $VOYA ahead of Q3 earnings and TCIM’s November 24 no-confidence referendum. Can certainly see a path to $150+ in a strategic takeout given the quality of the retirement franchise… My hesitation is how much activist premium is already embedded in the stock. Shares are up ~30% since TCIM surfaced in April, and the referendum is non-binding. If Q3 disappoints and the activist fails to gain traction, hard to see why this couldn’t trade back toward the pre-activist ~$75 level. Love the potential upside, less convinced by the asymmetry at ~$97… Thoughts welcome.
@StableBread

Fajasy on X

35% of TOYO Co., Ltd’s $TOYO H1 2026 revenue came from one customer it doesn’t name, and 22% came from companies under its own controlling shareholder. $TOYO manufactures solar cells, the processed silicon wafers that turn sunlight into electricity, and assembles some of them into panels (modules). Its cells use TOPCon (tunnel oxide passivated contact), a common high-efficiency silicon cell design. $TOYO runs three factories: 1) Ethiopia (4 GW of cells): Started production in April 2025, six months after $TOYO announced the plant, added a second 2 GW line in August, and reached its 4 GW nameplate in October 2025. 2) Vietnam (2 GW of cells): Running since H2 2023, but its cells now go to non-U.S. markets like India and Taiwan, since the U.S. Commerce Department set anti-dumping and countervailing duties (taxes on imports sold below cost or subsidized) on Vietnamese cells in April 2025. 3) Texas (2 GW of modules): A leased 567,140-square-foot plant near Houston that started its first 1 GW line in October 2025 and had completed its second by early October 2026. It assembles panels from $TOYO’s Ethiopian cells. VSUN (Vietnam Sunergy JSC) is the Vietnamese panel maker $TOYO was carved out of, and both companies sit under the same majority shareholder, Abalance, a Japanese solar group. VSUN is still $TOYO’s lender, owed $51.4M including interest, and a past wafer supplier through its Chinese subsidiary. $TOYO’s $261.0M of H1 2026 revenue came from four lines: → Third-party cells (56.5%): $147.6M of cells sold to outside module makers. → Related-party sales (22.0%): $57.5M of cells and modules sold to VSUN and its affiliates. → OEM services (14.2%): $37.2M of fees for cells made under one customer’s name, which $TOYO books net, counting only its fee as revenue. → Third-party modules (7.2%): $18.7M of Texas-made panels. Upstream, 70% of the polysilicon (the refined silicon that wafers are cut from) in $TOYO’s Ethiopian cells comes from a U.S. producer and the rest from OCI’s plant in Malaysia, Rhone Resch, $TOYO’s Chief Strategy Officer, said on the Q2 call. Resch also said its 2026 wafers come from non-China production, “including a designated facility in Indonesia.” $TOYO markets its supply chain as “non-FEOC,” free of any foreign entity of concern. U.S. buyers care, since the One Big Beautiful Bill Act (OBBBA) denies the main clean-power tax credit to projects with too much equipment from Prohibited Foreign Entities, a label aimed at Chinese suppliers.

Investor Letters

All letters

GREAT DEC-TECTIVE WORK

Diversified Energy reported $255.6 million of “true” nine-month free cash flow, while its $1.8 billion Birch acquisition would shift…

DEC $900M
The Oak Bloke 2 clicks
AAP · long

Advance Auto Parts INC

Advance Auto Parts, AAP, is presented as a long idea following prior write-ups at $48.81 per share in January 2025.

AAP $2.9B
Value Investors Club 1 click

Problems at Twist Bioscience (TWST)

Twist Bioscience’s $200 rebound followed an Anthropic-linked short squeeze, yet its DNA and protein services face broad competition while…

TWST $8B
Hunterbrook 4 clicks

VSH Earnings Review

Vishay reported record Q3 revenue of $979 million, up 24%, and guided Q4 to about $990 million as rising backlog and margins contrast with…

VSH $3.6B
Cestrian Capital Research 3 clicks

New Ideas From The Road

Aurelion Research increased healthcare exposure and sees opportunities in banking and defense, alongside research on Alcoa, Nike, ONON and…

MDA $4.2B
Aurelion Research 4 clicks

Publications we follow

Every publication on this site, hand-picked.

129 publications

Newsletters 109

YouTube 4

Blogs 15

Seeking Alpha 74 of 277

Nominate a publication

X accounts we follow

Every account on this site, hand-picked.

91 accounts
Nominate an account

Investor letters we follow

359 firms

Sectors

Ordered by how often our editor reaches for them.